ITCI logo

Intra-Cellular Therapies (ITCI) Price To Sales Ratio

PS Ratio

21.99
-0.03-0.14%

2 min ago


Summary


Performance

ITCI PS Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherITCIvaluationmetrics:

PS Ratio Formula

P/S =  
Market capitalization
TTM Revenue

ITCI PS Ratio Trends

PeriodPeriodPS ratioPS ratioPricePriceMarket capMarket capTTM revenueTTM revenue
todaytoday-0.1%-0.1%-0.1%+8.8%
1 m1 month+52.7%+52.7%+52.7%-
3 m3 months+39.4%+39.4%+39.4%+8.8%
6 m6 months+59.2%+72.6%+73.2%-
ytdytd+52.3%+52.3%+52.3%-
1 y1 year+59.4%+92.1%+111.3%+46.6%
5 y5 years-+495.1%+863.0%+46.6%

ITCI PS Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-0.3%14.10+56.0%
3 m3-month22.06-0.3%13.95+57.6%
6 m6-month22.06-0.3%12.26+79.4%
1 y1-year22.06-0.3%10.05+118.8%
3 y3-year71.12-69.1%10.05+118.8%
5 y5-year2005.94-98.9%10.05+118.8%
alltimeall time76.36 K-100.0%10.05+118.8%

Intra-Cellular Therapies PS Ratio History

DateValue
2025
21.99(+52.3%)
2024
14.44(-3.8%)
2023
15.01(-25.5%)
2022
20.14(-61.6%)
2021
52.45(-53.8%)
DateValue
2020
113.56(-96.5%)
2017
3215.03(+62.7%)
2016
1975.48(-97.4%)
2015
75.61 K(+7851.2%)
2014
950.98

FAQ

  • What is Intra-Cellular Therapies price to sales ratio?
  • What is the all time high PS ratio for Intra-Cellular Therapies?
  • What is ITCI price to sales ratio year-to-date change?
  • What is Intra-Cellular Therapies PS ratio year-on-year change?

What is Intra-Cellular Therapies price to sales ratio?

The current PS ratio of ITCI is 21.99

What is the all time high PS ratio for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high price to sales ratio is 76.36 K

What is ITCI price to sales ratio year-to-date change?

Intra-Cellular Therapies price to sales ratio has changed by +7.55 (+52.29%) since the beginning of the year

What is Intra-Cellular Therapies PS ratio year-on-year change?

Over the past year, ITCI price to sales ratio has changed by +8.19 (+59.35%)